Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/26/2870462/0/en/Allogene-Therapeutics-Awarded-Grant-from-the-California-Institute-for-Regenerative-Medicine-to-Advance-Development-of-an-Allogeneic-CAR-T-in-Renal-Cell-Carcinoma.html
https://www.globenewswire.com/news-release/2024/04/09/2859999/0/en/Allogene-Therapeutics-Announces-Q2-Investor-Conference-Participation.html
https://www.globenewswire.com//news-release/2024/03/14/2846685/0/en/Allogene-Therapeutics-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Business-Update.html
https://www.globenewswire.com//news-release/2024/03/12/2844522/0/en/Allogene-Therapeutics-and-Arbor-Biotechnologies-Announce-Global-Gene-Editing-Licensing-Agreement-to-Support-Advancement-of-Next-Generation-Allogeneic-CAR-T-Platform-in-Autoimmune-D.html
https://www.globenewswire.com//news-release/2024/03/05/2840441/0/en/Allogene-Therapeutics-to-Report-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Provide-Business-Update.html
https://www.globenewswire.com//news-release/2024/02/28/2836977/0/en/Allogene-Therapeutics-Announces-Participation-in-the-44th-Annual-TD-Cowen-Health-Care-Conference.html
https://www.globenewswire.com//news-release/2024/02/16/2830761/0/en/Allogene-Therapeutics-to-Restate-Previously-Filed-Financial-Statements-Recognizing-Non-Cash-Accounting-Adjustments-Related-to-the-December-2020-Formation-of-the-Allogene-Overland-B.html
https://www.globenewswire.com//news-release/2024/01/16/2810313/0/en/Allogene-Therapeutics-Announces-Participation-in-Upcoming-Investor-Conferences.html
https://www.fiercebiotech.com/biotech/allogene-makes-bold-pivot-stopping-pivotal-trials-pursuit-first-line-car-t-cures
https://www.globenewswire.com//news-release/2024/01/04/2804345/0/en/Allogene-Therapeutics-and-Foresight-Diagnostics-Announce-Partnership-to-Develop-MRD-based-In-Vitro-Diagnostic-for-Use-in-ALPHA3-the-First-Pivotal-Trial-for-Frontline-Consolidation-.html